Clinical trials sponsored by baotai Liang

Phase breakdown

Conditions studied

Recruiting trials led by baotai Liang

• A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
  NCT07250542 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: Male · 1 location
• Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
  NCT06861192 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 85 Years · Sex: Male · 1 location
• Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
  NCT06834321 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: Male · 2 locations
• Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
  NCT07163910 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: Male · 1 location

Common questions

How many trials is baotai Liang recruiting for?

baotai Liang is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.